Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer

NCT05747326 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences